Epidemiology of depression
- PMID: 1546146
- DOI: 10.1007/BF02246240
Epidemiology of depression
Abstract
Review of the published literature produces 1-year prevalence rates for major depressive disorder DSM-III between 2.6 and 6.2%, for dysthymia between 2.3 and 3.7%, bipolar disorder 1.0-1.7%. Data from the prospective Zurich Study with four interviews over 10 years give relatively high 10-year prevalence rates for subjects from age 20 to 30 (14.4% major depression, 10.5% recurrent brief depression, 0.9% dysthymia, 3.3% bipolar disorder, 1.3% hypomania). On average, 49% of all these cases received treatment for affective disorder, resulting in a weighted treatment prevalence rate of the population of 11.6% (18% for females and 5% for males). It has to be assumed that lifetime prevalence rates based on recall may greatly underestimate true morbidity.
Similar articles
-
The epidemiology of depressive disorders.Eur Neuropsychopharmacol. 1995;5 Suppl:95-8. doi: 10.1016/0924-977x(95)00025-k. Eur Neuropsychopharmacol. 1995. PMID: 8775766
-
[Hypomania. Apropos of a cohort of young patients].Encephale. 1992 Jan;18 Spec No 1:23-9. Encephale. 1992. PMID: 1600900 French.
-
Bipolar II disorder : epidemiology, diagnosis and management.CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003. CNS Drugs. 2007. PMID: 17696573 Review.
-
Treated versus non-treated subjects with depression from a 30-year cohort study: prevalence and clinical covariates.Eur Arch Psychiatry Clin Neurosci. 2016 Mar;266(2):173-80. doi: 10.1007/s00406-015-0646-5. Epub 2015 Oct 23. Eur Arch Psychiatry Clin Neurosci. 2016. PMID: 26499773
-
Major depression, dysthymia and depressive personality disorder.Br J Psychiatry Suppl. 1994 Dec;(26):23-30. Br J Psychiatry Suppl. 1994. PMID: 7873134 Review.
Cited by
-
Emotions as infectious diseases in a large social network: the SISa model.Proc Biol Sci. 2010 Dec 22;277(1701):3827-35. doi: 10.1098/rspb.2010.1217. Epub 2010 Jul 7. Proc Biol Sci. 2010. PMID: 20610424 Free PMC article.
-
Sertraline. A pharmacoeconomic evaluation of its use in depression.Pharmacoeconomics. 1996 Oct;10(4):409-31. doi: 10.2165/00019053-199610040-00009. Pharmacoeconomics. 1996. PMID: 10184609 Review.
-
Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin.Pharmacoeconomics. 1994 Mar;5(3):249-68. doi: 10.2165/00019053-199405030-00008. Pharmacoeconomics. 1994. PMID: 10146899
-
Stability and change in reported age of onset of depression, back pain, and smoking over 29 years in a prospective cohort study.J Psychiatr Res. 2017 May;88:105-112. doi: 10.1016/j.jpsychires.2017.01.005. Epub 2017 Jan 10. J Psychiatr Res. 2017. PMID: 28113111 Free PMC article.
-
The cost of depression in the elderly. Effects of drug therapy.Drugs Aging. 1997 Jan;10(1):59-68. doi: 10.2165/00002512-199710010-00006. Drugs Aging. 1997. PMID: 9111708 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical